1 Shibasaki, T (2008) Ornithine (in Japanese). In Frontier of Amino Acid Science and New Applications for Better Human Life, pp. 303–315 [Kadowaki, M, Torii, K and Takahashi, N, editors]. Tokyo: CMC Publishing Company.
2 Sugino, T, Shirai, T, Kajimoto, Y, et al. (2008) l-Ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism. Nutrition Res 28, 738–743.
3 Shih, VE, Efron, ML & Moser, HW (1969) Hyperornithinemia, hyperammonemia, and homocitrullinuria. A new disorder of amino acid metabolism associated with myoclonic seizures and mental retardation. Am J Dis Child 117, 83–92.
4 Simell, O & Takki, K (1973) Raised plasma-ornithine and gyrate atrophy of the choroid and retina. Lancet i, 1031–1033.
5 Palmieri, F (2008) Diseases caused by defects of mitochondrial carriers: a review. Biochim Biophys Acta 1777, 564–578.
6 Torisu, H (2009) Hyperornithinemia–hyperammonemia–homocitrullinuria syndrome (in Japanese). Shonika-Shinryo 72, 352.
7 Kuwabara, T, Ishikawa, Y & Kaiser-Kupfer, MI (1981) Experimental model of gyrate atrophy in animals. Ophthalmology 88, 331–334.
8 Elam, RP (1988) Morphological changes in adult males from resistance exercise and amino acid supplementation. J Sports Med 28, 35–39.
9 Elam, RP, Hardin, DH, Sutton, RAL, et al. (1989) Effects of arginine and ornithine on strength, lean body mass and urinary hydroxyproline in adult males. J Sports Med 29, 52–56.
10 Bucci, L, Hickson, JF Jr, Pivarnik, JM, et al. (1990) Ornithine ingestion and growth hormone release in bodybuilders. Nutrition Res 10, 239–245.
11 Müting, D, Kalk, JF & Klein, CP (1992) Long-term effectiveness of high-dosed ornithine-aspartate on urea synthesis rate and portal hypertension in human liver cirrhosis. Amino Acids 3, 147–153.
12 Brocker, P, Vellas, B, Albarede, JL, et al. (1994) A two-center, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects. Age Ageing 23, 303–306.
13 Debry, G & Poynard, T (1995) Value of ornithine alpha-ketoglutarate for nutritional support in convalescent, malnourished elderly subjects. Facts Res Gerontol 9, 165–176.
14 Gebhardt, R, Beckers, G, Gaunitz, F, et al. (1997) Treatment of cirrhotic rats with l-ornithine-l-aspartate enhances urea synthesis and lowers serum ammonia levels. J Pharmacol Exp Therap 283, 1–6.
15 De Bandt, JP, Coudray-Lucas, C, Lioret, N, et al. (1998) A randomized controlled trial of the influence of the mode of enteral ornithine alpha-ketoglutarate administration in burn patients. J Nutr 128, 563–569.
16 Blonde-Cynober, F, Aussel, C & Cynober, L (2003) Use of ornithine alpha-ketoglutarate in clinical nutrition of elderly patients. Nutrition 19, 73–75.
17 Meneguello, MO, Mendonca, JR, Lancha, AH Jr, et al. (2003) Effect of arginine, ornithine and citrulline supplementation upon performance and metabolism of trained rats. Cell Biochem Funct 21, 85–91.
18 Cynober, L (2004) Ornithine alpha-ketoglutarate as a potent precursor of arginine and nitric oxide: a new job for an old friend. J Nutr 134, 2858S–2862S.
19 Fell, V, Pollitt, RJ, Sampson, GA, et al. (1974) Ornithinemia, hyperammonemia, and homocitrullinuria. A disease associated with mental retardation and possibly caused by defective mitochondrial transport. Am J Dis Child 127, 752–756.
20 Simell, O, Mackenzie, S, Clow, CL, et al. (1985) Ornithine loading did not prevent induced hyperammonemia in a patient with hyperornithinemia–hyperammonemia–homocitrullinuria syndrome. Pediatr Res 19, 1283–1287.
21 Kirsch, SE & McInnes, RR (1986) Control of hyperammonemia in the 3H syndrome by ornithine supplementation. Pediatr Res 20, 267 .
22 Koike, R, Fujimori, K, Yuasa, T, et al. (1987) Hyperornithinemia, hyperammonemia and homocitrullinuria: case report and biochemical study. Neurology 37, 1813–1815.
23 Dionisi Vici, C, Bachmann, C, Gambarara, M, et al. (1987) Hyperornithinemia–hyperammonemia–homocitrullinuria syndrome: low creatine excretion and effect of citrulline, arginine, or ornithine supplement. Pediatr Res 22, 364–367.
24 Inoue, I, Saheki, T, Kayanuma, K, et al. (1988) Biochemical analysis of decreased ornithine transport activity in the liver mitochondria from patients with hyperornithinemia, hyperammonemia and homocirullinuria. Biochim Biophys Acta 964, 90–95.
25 Nakajima, M, Ishii, S, Mito, T, et al. (1988) Clinical, biochemical and ultrastructural study on the pathogenesis of hyperornithinemia–hyperammonemia–homocitrullinuria syndrome. Brain Dev 10, 181–185.
26 Tuchman, M, Knopman, DS & Shih, VE (1990) Episodic hyperammonemia in adult siblings with hyperornithinemia, hyperammonemia, and homocitrullinuria. Arch Neurol 47, 1134–1137.
27 Tsujino, S, Suzuki, T, Azuma, T, et al. (1991) Hyperornithinemia, hyperammonemia and homocitrullinuria – a case report and study of ornithine metabolism using in vivo deuterium labelling. Clin Chim Acta 201, 129–134.
28 Shigeto, H, Yamada, T, Kobayashi, T, et al. (1992) A case of hyperornithinemia–hyperammonemia–homocitrullinuria (HHH) syndrome with spastic paraparesis and severe distal muscle atrophy of lower limb (in Japanese). Clin Neurol 32, 729–732.
29 Lemay, JF, Lambert, MA & Mitchell, GA (1992) Hyperammonemia–hyperornithinemia–homocitrullinuria syndrome: neurologic, ophthalmologic, and neuropsychologic examination of six patients. J Pediatr 121, 725–730.
30 Zammarchi, E, Ciani, F & Pasquini, E (1997) Neonatal onset of hyperornithinemia–hyperammonemia–homocitrullinuria syndrome with favorable outcome. J Pediatr 131, 440–443.
31 Tessa, A, Fiermonte, G, Dionisi-Vici, C, et al. (2009) Identification of novel mutations in the SLC25A15 gene in hyperornithinemia–hyperammonemia–homocitrullinuria (HHH) syndrome. A clinical, molecular, and functional study. Hum Mut 30, 741–748.
32 Salvi, S, Santorelli, FM, Bertini, E, et al. (2001) Clinical and molecular findings in hyperornithinemia–hyperammonemia–homocitrullinuria syndrome. Neurology 57, 911–914.
33 Shimizu, H, Maekawa, K & Eto, Y (1990) Abnormal urinary excretion of polyamines in HHH syndrome (hyperornithinemia-associated with hyperammonemia and homocitrullinuria). Brain Dev 12, 533–535.
34 Camacho, JA, Obie, C, Biery, B, et al. (1999) Hyperornithinemia–hyperammonemia–homocitrullinuria syndrome is caused by mutations in gene encoding a mitochondrial ornithine transporter. Nat Genet 22, 151–158.
35 Tsujino, S, Kanazawa, N, Ohashi, T, et al. (2000) Three novel mutations (G27E, insAAC, R179X) in the ORNT1 gene of Japanese patients with hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome. Ann Neurol 47, 625–631.
36 Camacho, J, Mardach, R, Rioseco-Camacho, N, et al. (2006) Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia–hyperammonemia–homocitrullinuria (HHH) syndrome. Pediatr Res 60, 423–429.
37 Indiveri, C, Tonazzi, A & Palmieri, F (1992) Identification and purification of the ornithine/citrulline carrier from rat liver mitochondria. Eur J Biochem 207, 449–454.
38 Indiveri, C, Tonazzi, A, Stipani, I, et al. (1997) The purified and reconstituted ornithine/citrulline carrier from rat liver mitochondria: electrical nature and coupling of the exchange reaction with H+ translocation. Biochem J 327, 349–355.
39 Fiermonte, G, Dolce, V, David, L, et al. (2003) The mitochondrial ornithine transporter. Bacterial expression, reconstitution, functional characterization, and tissue distribution of two human isoforms. J Biol Chem 278, 32778–32783.
40 Burlina, AB, Ferrari, V, Dionisi-Vici, C, et al. (1992) Allopurinol challenge test in children. J Inher Metab Dis 15, 707–712.
41 Amaral, AU, Lerpnitz, G, Fernandes, CG, et al. (2009) Evidence that the major metabolites accumulating in hyperornithinemia–hyperammonemia–homocitrullinuria syndrome induce oxidative stress in brain of young rats. Int J Dev Neurosci 27, 635–641.
42 Berson, EL, Schmidt, SY & Rabin, A (1976) Plasma amino-acids in hereditary retinal disease: ornithine, lysine, and taurine. Br J Ophthalmol 60, 142–147.
43 Morini, C, Capozzi, P, Boenzi, S, et al. (2009) Retinal degeneration. Arch Ophthalmol 116, 1593.
44 Takki, K (1974) Gyrate atrophy of the choroid and retina associated with hyperornithinemia. Br J Ophthalmol 58, 3–23.
45 Takki, K & Simell, O (1974) Genetic aspects in gyrate atrophy of the choroid and retina with hyperornithinemia. Br J Ophthalmol 58, 907–916.
46 Takki, K & Simell, O (1976) Gyrate atrophy of the choroid and retina with hyperornithinemia. Birth Defects 12, 373–384.
47 Akiya, S, Osawa, M & Ogata, T (1977) The long-term observation of two brothers with gyrate atrophy of the choroid and retina with hyperornithinemia (in Japanese with English summary). Acta Soc Ophthalmol Jpn 91, 310–322.
48 Sipila, I, Simell, O & Arjomaa, P (1980) Gyrate atrophy of the choroid and retina with hyperornithinemia. Deficient formation of guanidinoacetic acid from arginine. J Clin Invest 66, 684–687.
49 Hayasaka, S, Saito, T, Nakajima, H, et al. (1981) Gyrate atrophy with hyperornithinemia: different types of responsiveness to vitamin B6. Br J Ophthalmol 65, 478–483.
50 Saito, T, Omura, K, Hayasaka, S, et al. (1981) Hyperornithinemia with gyrate atrophy of the choroid and retina: a disturbance in de novo formation of proline. Tohoku J Exp Med 135, 395–402.
51 Kaiser-Kupfer, M, Kuwabara, T, Uga, S, et al. (1983) Cataract in gyrate atrophy: clinical and morphologic studies. Invest Ophthalmol Vis Sci 24, 432–436.
52 Hayasaka, S, Saito, T, Nakajima, H, et al. (1985) Clinical trials of vitamin B6 and proline supplementation for gyrate atrophy of the choroid and retina. Br J Ophthalmol 69, 283–290.
53 Takahashi, O, Hayasaka, S, Kiyosawa, M, et al. (1985) Gyrate atrophy of the choroid and retina complicated by vitreous hemorrhage. Jpn J Ophthalmol 29, 170–176.
54 Hayasaka, S, Shiono, T, Mizuno, K, et al. (1986) Gyrate atrophy of the choroid and retina: 15 Japanese patients. Br J Ophthalmol 70, 612–614.
55 Fukazawa, S (2001) A case of gyrate atrophy of the choroid and retina (in Japanese with English abstract). Jpn J Clin Ophthalmol (Rinsho Ganka) 55, 996–999.
56 Ohkubo, Y, Ueta, A, Ito, T, et al. (2005) Vitamin B6-responsive ornithine aminotransferase deficiency with a novel mutation G237D. Tohoku J Exp Med 205, 335–342.
57 Kondo, Y, Yamamoto, H, Imai, H, et al. (2006) A case of gyrate chorioretinal atrophy with OAT gene mutation (in Japanese with English abstract). Jpn J Clin Ophthalmol (Rinsho Ganka) 60, 1191–1195.
58 Heinanen, K, Nanto-Salonen, K, Komu, M, et al. (1999) Muscle creatine phosphate in gyrate atrophy of the choroid and retina with hyperornithinemia – clues to pathogenesis. Eur J Clin Invest 29, 426–431.
59 Heinanen, K, Nanto-Salonen, K, Komu, M, et al. (1999) Creatine corrects muscle 31P spectrum in gyrate atrophy with hyperornithinemia. Eur J Clin Invest 29, 1060–1065.
60 Nanto-Salonen, K, Komu, M, Lundbom, N, et al. (1999) Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia. Neurology 53, 303–307.
61 Sengers, RCA, Trijbels, JMF, Brussaart, JH, et al. (1976) Gyrate atrophy of the choroid and retina and ornithine-ketoacid aminotransferase deficiency. Pediatr Res 10, 894.
62 Shih, VE, Berson, EL, Mandell, R, et al. (1978) Ornithine ketoacid transaminase deficiency in gyrate atrophy of the choroid and retina. Am J Hum Genet 30, 174–179.
63 Kaiser-Kupfer, MI, Valle, D & Del Valle, L (1978) A specific enzyme defect in gyrate atrophy. Am J Ophthalmol 85, 2000–2004.
64 Ramesh, V, McClatchey, AI, Ramesh, N, et al. (1998) Molecular basis of ornithine aminotransferase deficiency in B-6-responsive and nonresponsive forms of gyrate atrophy. Proc Natl Acad Sci U S A 85, 3777–3780.
65 Mitchell, GA, Brody, LC, Looney, J, et al. (1988) An initiator codon mutation in ornithine aminotransferase causing gyrate atrophy of the choroid and retina. J Clin Invest 81, 630–633.
66 Inana, G, Chambers, C, Hotta, Y, et al. (1989) Point mutation affecting processing of the ornithine aminotransferase precursor protein in gyrate atrophy. J Biol Chem 264, 17432–17436.
67 Mashima, Y, Murakami, A, Weleber, RG, et al. (1992) Nonsense-codon mutations of the ornithine aminotransferase gene with decreased levels of mutant mRNA in gyrate atrophy. Am J Hum Genet 51, 81–91.
68 Brody, LC, Mitchell, GA, Obie, C, et al. (1992) Ornithine aminotransferase mutations in gyrate atrophy. J Biol Chem 267, 3302–3307.
69 Park, JK, Herron, BJ, O'Donnell, J, et al. (1992) Three novel mutations of the ornithine aminotransferase (OAT) gene in gyrate atrophy. Genomics 14, 553–554.
70 Mashima, Y, Shiono, T, Tamai, M, et al. (1996) Heterogeneity and uniqueness of ornithine aminotransferase mutations found in Japanese gyrate atrophy patients. Curr Eye Res 15, 792–796.
71 Heinanen, K, Nanto-Salonen, K, Leino, L, et al. (1998) Gyrate atrophy of the choroid and retina: lymphocyte ornithine-delta-aminotransferase activity in different mutations and carriers. Pediatr Res 44, 381–385.
72 Peltola, KE, Nanto-Salonen, K, Heinonen, OJ, et al. (2001) Ophthalmologic heterogeneity in subjects with gyrate atrophy of choroid and retina harboring the L402P mutation of ornithine aminotransferase. Ophthalmology 108, 721–729.
73 Vannas-Sulonen, K, Sipila, I, Vannas, A, et al. (1985) Gyrate atrophy of the choroid and retina. A five-year follow-up of creatine supplementation. Ophthalmology 92, 1719–1727.
74 Kaiser-Kupfer, MI, Caruso, R & Valle, D (1991) Gyrate atrophy of the choroid and retina. Arch Ophthalmol 109, 1539–1548.
75 Kaiser-Kupfer, MI, Caruso, R, Valle, D, et al. (2002) Gyrate atrophy of the choroid and retina. Further experience with long-term reduction of ornithine levels in children. Arch Ophthalmol 120, 146–153.
76 Kaiser-Kupfer, MI, Caruso, RC, Valle, D, et al. (2004) Use of an arginine-restricted diet to slow progression of visual loss in patients with gyrate atrophy. Arch Ophthalmol 122, 982–984.
77 Ishikawa, Y, Kuwabara, T & Kaiser-Kupfer, MI (1982) Toxic effects of ornithine and its related compounds on the retina. Adv Exp Med Biol 153, 371–378.
78 Takeuchi, M, Itagaki, T, Takahashi, K, et al. (1991) Retinal degeneration after intravitreal injection of ornithine: early change after administration (in Japanese with English summary). Acta Soc Ophthalmol Jpn 94, 1012–1023.
79 Hiroi, K, Yamamoto, F & Honda, Y (1995) Effects of ornithine on the electroretinogram in cat retina. Invest Ophthalmol Vis Sci 36, 1732–1737.
80 Wang, T, Milam, AH, Steel, G, et al. (1996) A mouse model of gyrate atrophy of the choroid and retina. J Clin Invest 97, 2753–2762.
81 Wang, T, Steel, G, Milam, AH, et al. (2000) Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina. Proc Natl Acad Sci U S A 97, 1224–1229.
82 Ueda, M, Masu, Y, Ando, A, et al. (1998) Prevention of ornithine cytotoxicity by proline in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 39, 820–827.
83 Ando, A, Ueda, M, Uyama, M, et al. (2000) Heterogeneity in ornithine cytotoxicity of bovine retinal pigment epithelial cells in primary culture. Exp Eye Res 70, 89–96.
84 Nakauchi, T, Ando, A, Ueda-Yamada, M, et al. (2003) Prevention of ornithine cytotoxicity by nonpolar side chain amino acids in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 44, 5023–5028.
85 Kaneko, S, Ando, A, Okuda-Ashitaka, E, et al. (2007) Ornithine transport via cationic amino acid transporter-1 is involved in ornithine cytotoxicity in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 48, 464–471.
86 Kaneko, S, Ueda-Yamada, M, Ando, A, et al. (2007) Cytotoxic effect of spermine on retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 48, 455–463.
87 Hayasaka, S, Shiono, T, Takaku, Y, et al. (1980) Ornithine ketoacid aminotransferase in the bovine eye. Invest Ophthalmol Vis Sci 19, 1457–1460.
88 Shiono, T, Hayasaka, S & Mizuno, K (1982) Presence of ornithine ketoacid aminotransferase in human ocular tissues. Graefe's Arch Ophthalmol 218, 34–36.
89 Takahashi, O, Ishiguro, S, Mito, T, et al. (1987) Immunocytochemical localization of ornithine aminotransferase in rat ocular tissues. Invest Ophthalmol Vis Sci 28, 617–619.
90 Hayasaka, S, Matsuzawa, T, Shiono, T, et al. (1982) Enzymes metabolizing ornithine–proline pathway in the bovine eye. Exp Eye Res 34, 635–638.
91 Koshiyama, Y, Gotoh, T, Miyanaka, K, et al. (2000) Expression and localization of enzymes of arginine metabolism in the rat eye. Curr Eye Res 20, 313–321.
92 Marescau, B, de Deyn, PP, Lowenthal, A, et al. (1990) Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy. Pediatr Res 27, 297–303.
93 Nakajima, H & Mizuno, K (1983) Retinal changes after intravitreal injection of amino acids in the rabbit (in Japanese with English summary). Acta Soc Ophthalmol Jpn 87, 903–910.
94 Kuwabawa, T (1979) Species differences in the retinal pigment epithelium. In The Retinal Pigment Epithelium, pp. 58–82 [Zinn, KM and Marmor, MF, editors]. Cambridge, MA: Harvard University.